| SC 13G/A | 2021-02-08 | FMR LLC | Zai Lab Ltd | 8,117,324 | 9.2% | EDGAR |
| SC 13G/A | 2021-02-04 | Du Ying | Zai Lab Ltd | 5,894,388 | 6.5% | EDGAR |
| SC 13G | 2020-12-09 | Capital World Investors | Zai Lab Ltd | 9,431,255 | 10.7% | EDGAR |
| SC 13G/A | 2020-02-14 | Du Ying | Zai Lab Ltd | 7,923,455 | 11.2% | EDGAR |
| SC 13G/A | 2020-02-14 | Qiming Venture Partners IV, L.P. | Zai Lab Ltd | 9,072,932 | 13.3% | EDGAR |
| SC 13G/A | 2020-02-14 | SC CHINA HOLDING Ltd | Zai Lab Ltd | 1,567,796 | 2.6% | EDGAR |
| SC 13G/A | 2020-02-13 | KPCB China Fund II, L.P. | Zai Lab Ltd | 3,155,620 | 4.7% | EDGAR |
| SC 13G/A | 2020-02-11 | Advantech Capital L.P. | Zai Lab Ltd | 4,551,772 | 6.7% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | Zai Lab Ltd | 6,737,550 | 10.0% | EDGAR |
| SC 13G/A | 2020-02-03 | Segantii Capital Management Ltd | Zai Lab Ltd | 3,367,300 | 4.9% | EDGAR |
| SC 13G | 2019-05-10 | Segantii Capital Management Ltd | Zai Lab Ltd | 3,403,861 | 5.1% | EDGAR |
| SC 13G/A | 2019-03-22 | KPCB China Fund II, L.P. | Zai Lab Ltd | 3,437,311 | 5.9% | EDGAR |
| SC 13G/A | 2019-02-14 | Du Ying | Zai Lab Ltd | 9,399,089 | 15.6% | EDGAR |
| SC 13G/A | 2019-02-13 | FMR LLC | Zai Lab Ltd | 5,810,578 | 10.0% | EDGAR |
| SC 13G/A | 2019-02-13 | Qiming Venture Partners IV, L.P. | Zai Lab Ltd | 10,470,933 | 17.9% | EDGAR |
| SC 13G/A | 2018-05-31 | Du Ying | Zai Lab Ltd | 9,081,075 | 17.4% | EDGAR |
| SC 13G | 2018-02-26 | Du Ying | Zai Lab Ltd | 8,854,130 | 17.1% | EDGAR |
| SC 13G | 2018-02-14 | Qiming Venture Partners IV, L.P. | Zai Lab Ltd | 10,470,933 | 20.7% | EDGAR |
| SC 13G | 2018-02-14 | KPCB China Fund II, L.P. | Zai Lab Ltd | 3,787,311 | 7.7% | EDGAR |
| SC 13G | 2018-02-14 | SEQUOIA CAPITAL CV IV HOLDCO, LTD. | Zai Lab Ltd | 2,986,278 | 6.1% | EDGAR |